Selected research
Industry Research
Customized Cell Line Construction Service Industry Research Report 2026
Market perspective
The global Customized Cell Line Construction Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Customized Cell Line Construction Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Customized Cell Line Construction Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Customized Cell Line Construction Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Customized Cell Line Construction Service include Thermo Fisher Scientific Inc., Lonza Group AG, Sartorius Stedim Biotech S.A., GenScript Biotech Corporation, WuXi AppTec, Charles River Laboratories International, Inc., Bio-Rad Laboratories, Inc., Creative Biolabs and Sino Biological Inc., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Customized Cell Line Construction Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Customized Cell Line Construction Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Customized Cell Line Construction Service Market by Company
Thermo Fisher Scientific Inc.
Lonza Group AG
Sartorius Stedim Biotech S.A.
GenScript Biotech Corporation
WuXi AppTec
Charles River Laboratories International, Inc.
Bio-Rad Laboratories, Inc.
Creative Biolabs
Sino Biological Inc.
Evotec SE
Cyagen Biosciences
ATCC (American Type Culture Collection)
GenTarget Inc.
Applied Biological Materials Inc. (ABM)
Abnova Corporation
Transomic Technologies Inc.
BIOCYTOGEN
Crown Bioscience (Jiangsu)
Selexis SA (A KBI Company)
Viva Biotech Holdings
Customized Cell Line Construction Service Segment by Type
CHO Cells
HEK293
BHK
Vero
Hybridoma
Others
Customized Cell Line Construction Service Segment by Application
Pharmaceuticals
Research
Other
Customized Cell Line Construction Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Customized Cell Line Construction Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Customized Cell Line Construction Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Customized Cell Line Construction Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Customized Cell Line Construction Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CHO Cells
- HEK293
- BHK
- Vero
- Hybridoma
- Others
Applications
- Pharmaceuticals
- Research
- Other
Companies covered
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- Sartorius Stedim Biotech S.A.
- GenScript Biotech Corporation
- WuXi AppTec
- Charles River Laboratories International, Inc.
- Bio-Rad Laboratories, Inc.
- Creative Biolabs
- Sino Biological Inc.
- Evotec SE
- Cyagen Biosciences
- ATCC (American Type Culture Collection)
- GenTarget Inc.
- Applied Biological Materials Inc. (ABM)
- Abnova Corporation
- Transomic Technologies Inc.
- BIOCYTOGEN
- Crown Bioscience (Jiangsu)
- Selexis SA (A KBI Company)
- Viva Biotech Holdings
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Customized Cell Line Construction Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 CHO Cells
- 2.2.3 HEK293
- 2.2.4 BHK
- 2.2.5 Vero
- 2.2.6 Hybridoma
- 2.2.7 Others
- 2.3 Customized Cell Line Construction Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Research
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Customized Cell Line Construction Service Breakdown Data by Type
- 3.1 Global Customized Cell Line Construction Service Historic Market Size by Type (2021-2026)
- 3.2 Global Customized Cell Line Construction Service Forecasted Market Size by Type (2027-2032)
4 Customized Cell Line Construction Service Breakdown Data by Application
- 4.1 Global Customized Cell Line Construction Service Historic Market Size by Application (2021-2026)
- 4.2 Global Customized Cell Line Construction Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Customized Cell Line Construction Service Market Perspective (2021-2032)
- 5.2 Global Customized Cell Line Construction Service Growth Trends by Region
- 5.2.1 Global Customized Cell Line Construction Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Customized Cell Line Construction Service Historic Market Size by Region (2021-2026)
- 5.2.3 Customized Cell Line Construction Service Forecasted Market Size by Region (2027-2032)
- 5.3 Customized Cell Line Construction Service Market Dynamics
- 5.3.1 Customized Cell Line Construction Service Industry Trends
- 5.3.2 Customized Cell Line Construction Service Market Drivers
- 5.3.3 Customized Cell Line Construction Service Market Challenges
- 5.3.4 Customized Cell Line Construction Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Customized Cell Line Construction Service Players by Revenue
- 6.1.1 Global Top Customized Cell Line Construction Service Players by Revenue (2021-2026)
- 6.1.2 Global Customized Cell Line Construction Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Customized Cell Line Construction Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Customized Cell Line Construction Service Head Office and Area Served
- 6.4 Global Customized Cell Line Construction Service Players, Product Type & Application
- 6.5 Global Customized Cell Line Construction Service Manufacturers Established Date
- 6.6 Global Customized Cell Line Construction Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Customized Cell Line Construction Service Market Size (2021-2032)
- 7.2 North America Customized Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Customized Cell Line Construction Service Market Size by Country (2021-2026)
- 7.4 North America Customized Cell Line Construction Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Customized Cell Line Construction Service Market Size (2021-2032)
- 8.2 Europe Customized Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Customized Cell Line Construction Service Market Size by Country (2021-2026)
- 8.4 Europe Customized Cell Line Construction Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Customized Cell Line Construction Service Market Size (2021-2032)
- 9.2 Asia-Pacific Customized Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Customized Cell Line Construction Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Customized Cell Line Construction Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Customized Cell Line Construction Service Market Size (2021-2032)
- 10.2 South America Customized Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Customized Cell Line Construction Service Market Size by Country (2021-2026)
- 10.4 South America Customized Cell Line Construction Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Customized Cell Line Construction Service Market Size (2021-2032)
- 11.2 Middle East & Africa Customized Cell Line Construction Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Customized Cell Line Construction Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Customized Cell Line Construction Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific Inc.
- 12.1.1 Thermo Fisher Scientific Inc. Company Information
- 12.1.2 Thermo Fisher Scientific Inc. Business Overview
- 12.1.3 Thermo Fisher Scientific Inc. Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Inc. Customized Cell Line Construction Service Product Portfolio
- 12.1.5 Thermo Fisher Scientific Inc. Recent Developments
- 12.2 Lonza Group AG
- 12.2.1 Lonza Group AG Company Information
- 12.2.2 Lonza Group AG Business Overview
- 12.2.3 Lonza Group AG Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.2.4 Lonza Group AG Customized Cell Line Construction Service Product Portfolio
- 12.2.5 Lonza Group AG Recent Developments
- 12.3 Sartorius Stedim Biotech S.A.
- 12.3.1 Sartorius Stedim Biotech S.A. Company Information
- 12.3.2 Sartorius Stedim Biotech S.A. Business Overview
- 12.3.3 Sartorius Stedim Biotech S.A. Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.3.4 Sartorius Stedim Biotech S.A. Customized Cell Line Construction Service Product Portfolio
- 12.3.5 Sartorius Stedim Biotech S.A. Recent Developments
- 12.4 GenScript Biotech Corporation
- 12.4.1 GenScript Biotech Corporation Company Information
- 12.4.2 GenScript Biotech Corporation Business Overview
- 12.4.3 GenScript Biotech Corporation Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.4.4 GenScript Biotech Corporation Customized Cell Line Construction Service Product Portfolio
- 12.4.5 GenScript Biotech Corporation Recent Developments
- 12.5 WuXi AppTec
- 12.5.1 WuXi AppTec Company Information
- 12.5.2 WuXi AppTec Business Overview
- 12.5.3 WuXi AppTec Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.5.4 WuXi AppTec Customized Cell Line Construction Service Product Portfolio
- 12.5.5 WuXi AppTec Recent Developments
- 12.6 Charles River Laboratories International, Inc.
- 12.6.1 Charles River Laboratories International, Inc. Company Information
- 12.6.2 Charles River Laboratories International, Inc. Business Overview
- 12.6.3 Charles River Laboratories International, Inc. Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.6.4 Charles River Laboratories International, Inc. Customized Cell Line Construction Service Product Portfolio
- 12.6.5 Charles River Laboratories International, Inc. Recent Developments
- 12.7 Bio-Rad Laboratories, Inc.
- 12.7.1 Bio-Rad Laboratories, Inc. Company Information
- 12.7.2 Bio-Rad Laboratories, Inc. Business Overview
- 12.7.3 Bio-Rad Laboratories, Inc. Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.7.4 Bio-Rad Laboratories, Inc. Customized Cell Line Construction Service Product Portfolio
- 12.7.5 Bio-Rad Laboratories, Inc. Recent Developments
- 12.8 Creative Biolabs
- 12.8.1 Creative Biolabs Company Information
- 12.8.2 Creative Biolabs Business Overview
- 12.8.3 Creative Biolabs Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.8.4 Creative Biolabs Customized Cell Line Construction Service Product Portfolio
- 12.8.5 Creative Biolabs Recent Developments
- 12.9 Sino Biological Inc.
- 12.9.1 Sino Biological Inc. Company Information
- 12.9.2 Sino Biological Inc. Business Overview
- 12.9.3 Sino Biological Inc. Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.9.4 Sino Biological Inc. Customized Cell Line Construction Service Product Portfolio
- 12.9.5 Sino Biological Inc. Recent Developments
- 12.10 Evotec SE
- 12.10.1 Evotec SE Company Information
- 12.10.2 Evotec SE Business Overview
- 12.10.3 Evotec SE Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.10.4 Evotec SE Customized Cell Line Construction Service Product Portfolio
- 12.10.5 Evotec SE Recent Developments
- 12.11 Cyagen Biosciences
- 12.11.1 Cyagen Biosciences Company Information
- 12.11.2 Cyagen Biosciences Business Overview
- 12.11.3 Cyagen Biosciences Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.11.4 Cyagen Biosciences Customized Cell Line Construction Service Product Portfolio
- 12.11.5 Cyagen Biosciences Recent Developments
- 12.12 ATCC (American Type Culture Collection)
- 12.12.1 ATCC (American Type Culture Collection) Company Information
- 12.12.2 ATCC (American Type Culture Collection) Business Overview
- 12.12.3 ATCC (American Type Culture Collection) Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.12.4 ATCC (American Type Culture Collection) Customized Cell Line Construction Service Product Portfolio
- 12.12.5 ATCC (American Type Culture Collection) Recent Developments
- 12.13 GenTarget Inc.
- 12.13.1 GenTarget Inc. Company Information
- 12.13.2 GenTarget Inc. Business Overview
- 12.13.3 GenTarget Inc. Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.13.4 GenTarget Inc. Customized Cell Line Construction Service Product Portfolio
- 12.13.5 GenTarget Inc. Recent Developments
- 12.14 Applied Biological Materials Inc. (ABM)
- 12.14.1 Applied Biological Materials Inc. (ABM) Company Information
- 12.14.2 Applied Biological Materials Inc. (ABM) Business Overview
- 12.14.3 Applied Biological Materials Inc. (ABM) Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.14.4 Applied Biological Materials Inc. (ABM) Customized Cell Line Construction Service Product Portfolio
- 12.14.5 Applied Biological Materials Inc. (ABM) Recent Developments
- 12.15 Abnova Corporation
- 12.15.1 Abnova Corporation Company Information
- 12.15.2 Abnova Corporation Business Overview
- 12.15.3 Abnova Corporation Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.15.4 Abnova Corporation Customized Cell Line Construction Service Product Portfolio
- 12.15.5 Abnova Corporation Recent Developments
- 12.16 Transomic Technologies Inc.
- 12.16.1 Transomic Technologies Inc. Company Information
- 12.16.2 Transomic Technologies Inc. Business Overview
- 12.16.3 Transomic Technologies Inc. Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.16.4 Transomic Technologies Inc. Customized Cell Line Construction Service Product Portfolio
- 12.16.5 Transomic Technologies Inc. Recent Developments
- 12.17 BIOCYTOGEN
- 12.17.1 BIOCYTOGEN Company Information
- 12.17.2 BIOCYTOGEN Business Overview
- 12.17.3 BIOCYTOGEN Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.17.4 BIOCYTOGEN Customized Cell Line Construction Service Product Portfolio
- 12.17.5 BIOCYTOGEN Recent Developments
- 12.18 Crown Bioscience (Jiangsu)
- 12.18.1 Crown Bioscience (Jiangsu) Company Information
- 12.18.2 Crown Bioscience (Jiangsu) Business Overview
- 12.18.3 Crown Bioscience (Jiangsu) Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.18.4 Crown Bioscience (Jiangsu) Customized Cell Line Construction Service Product Portfolio
- 12.18.5 Crown Bioscience (Jiangsu) Recent Developments
- 12.19 Selexis SA (A KBI Company)
- 12.19.1 Selexis SA (A KBI Company) Company Information
- 12.19.2 Selexis SA (A KBI Company) Business Overview
- 12.19.3 Selexis SA (A KBI Company) Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.19.4 Selexis SA (A KBI Company) Customized Cell Line Construction Service Product Portfolio
- 12.19.5 Selexis SA (A KBI Company) Recent Developments
- 12.20 Viva Biotech Holdings
- 12.20.1 Viva Biotech Holdings Company Information
- 12.20.2 Viva Biotech Holdings Business Overview
- 12.20.3 Viva Biotech Holdings Revenue in Customized Cell Line Construction Service Business (2021-2026)
- 12.20.4 Viva Biotech Holdings Customized Cell Line Construction Service Product Portfolio
- 12.20.5 Viva Biotech Holdings Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst